Benzinga | May 5, 2021 04:23PM EDT

Evolent Health Q1 Adj. EPS $(0.01) Beats $(0.06) Estimate, Sales $215.10M Beat $212.79M Estimate

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.06) by 83.33 percent. This is a 92.86 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $215.10 million which beat the analyst consensus estimate of $212.79 million by 1.09 percent. This is a 13.02 percent decrease over sales of $247.28 million the same period last year.